PIETROLUONGO, DARIA
 Distribuzione geografica
Continente #
AS - Asia 174
NA - Nord America 72
EU - Europa 68
SA - Sud America 23
OC - Oceania 3
AF - Africa 2
Totale 342
Nazione #
SG - Singapore 68
US - Stati Uniti d'America 62
CN - Cina 53
HK - Hong Kong 30
RU - Federazione Russa 24
IT - Italia 22
BR - Brasile 18
VN - Vietnam 10
DE - Germania 6
FI - Finlandia 6
CA - Canada 5
KR - Corea 5
MX - Messico 4
GB - Regno Unito 3
NL - Olanda 3
AR - Argentina 2
EC - Ecuador 2
IN - India 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
FR - Francia 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
NZ - Nuova Zelanda 1
PW - Palau 1
SV - El Salvador 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 342
Città #
Singapore 38
Hong Kong 30
Hefei 28
Naples 15
Ashburn 12
Los Angeles 10
New York 9
Beijing 7
Moscow 7
Seoul 5
Ho Chi Minh City 4
Munich 4
Turku 4
Montreal 3
San Jose 3
São Paulo 3
Atlanta 2
Boardman 2
Chaozhou 2
Dallas 2
Guangzhou 2
Guayaquil 2
Orem 2
Querétaro 2
Thái Nguyên 2
Warsaw 2
Altoona 1
Ankara 1
Araguari 1
Araxá 1
Baghdad 1
Belo Horizonte 1
Belém 1
Bengaluru 1
Brasília 1
Buffalo 1
Caivano 1
Cape Town 1
City of London 1
Crispiano 1
Denver 1
Dongguan 1
Frankfurt am Main 1
Gramado 1
Guarulhos 1
Hanoi 1
Helsinki 1
Honolulu 1
Hải Dương 1
Itajubá 1
Kochi 1
Lappeenranta 1
Long Xuyen 1
Lấp Vò 1
Marseille 1
Mexico City 1
Miramar 1
Misterbianco 1
Ngerulmud 1
Nova Friburgo 1
Nuremberg 1
Padre Hurtado 1
Paranaíba 1
Passo Fundo 1
Portsmouth 1
Prague 1
Queimados 1
Rome 1
San Carlos de Bolívar 1
San Salvador 1
Santana de Parnaíba 1
Surabaya 1
Sydney 1
São Carlos 1
São Roque 1
Teramo 1
Tokyo 1
Toronto 1
Torreón 1
Wellington 1
Whitby 1
Totale 257
Nome #
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 128
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 113
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 106
Totale 347
Categoria #
all - tutte 634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025105 0 0 0 0 0 5 5 3 3 7 17 65
2025/2026242 35 50 37 54 47 15 4 0 0 0 0 0
Totale 347